US Stock MarketDetailed Quotes

Sagimet Biosciences (SGMT)

Watchlist
  • 6.900
  • -0.470-6.38%
Close May 15 16:00 ET
  • 7.020
  • +0.120+1.74%
Post 20:01 ET
426.09MMarket Cap-5.11P/E (TTM)

Sagimet Biosciences (SGMT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
40.76%-8.61M
-7.58%-45.65M
-7.34%-11.83M
47.98%-10.18M
-61.54%-9.1M
-134.15%-14.54M
-78.55%-42.44M
-55.64%-11.02M
-404.49%-19.57M
1.50%-5.63M
Net income from continuing operations
41.41%-10.65M
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
Other non cash items
0.00%39K
4.14%151K
0.00%37K
0.00%37K
8.57%38K
8.33%39K
4.32%145K
2.78%37K
5.71%37K
2.94%35K
Change In working capital
-88.70%301K
-0.48%-1.05M
-217.23%-4.29M
111.67%701K
-108.46%-125K
1,571.82%2.66M
-7.16%-1.05M
1,407.86%3.66M
-1,123.17%-6.01M
7,485.00%1.48M
-Change in prepaid assets
56.77%-297K
-36,500.00%-1.83M
-108.69%-283K
80.85%-825K
-108.58%-35K
-207.34%-687K
99.47%-5K
679.36%3.26M
-463.27%-4.31M
-0.97%408K
-Change in payables and accrued expense
-81.21%637K
202.43%929K
-994.82%-3.97M
194.16%1.56M
-104.67%-51K
533.50%3.39M
-855.83%-907K
38.75%444K
-219.51%-1.66M
375.51%1.09M
-Change in other current liabilities
0.00%-39K
-11.76%-152K
2.63%-37K
0.00%-37K
-77.27%-39K
0.00%-39K
6.85%-136K
0.00%-38K
0.00%-37K
38.89%-22K
Cash from discontinued investing activities
Operating cash flow
40.76%-8.61M
-7.58%-45.65M
-7.34%-11.83M
47.98%-10.18M
-61.54%-9.1M
-134.15%-14.54M
-78.55%-42.44M
-55.64%-11.02M
-404.49%-19.57M
1.50%-5.63M
Investing cash flow
Cash flow from continuing investing activities
199.33%10.22M
107.39%4.56M
45.77%14.36M
-87.98%75K
82.32%-13.29M
13.77%3.41M
-590.33%-61.68M
150.20%9.85M
624K
-687.16%-75.16M
Net investment purchase and sale
199.33%10.22M
107.39%4.56M
45.77%14.36M
-87.98%75K
82.32%-13.29M
13.77%3.41M
-590.33%-61.68M
150.20%9.85M
--624K
-687.16%-75.16M
Cash from discontinued investing activities
Investing cash flow
199.33%10.22M
107.39%4.56M
45.77%14.36M
-87.98%75K
82.32%-13.29M
13.77%3.41M
-590.33%-61.68M
150.20%9.85M
--624K
-687.16%-75.16M
Financing cash flow
Cash flow from continuing financing activities
-99.74%275K
0
274K
103.70%1K
0
21.65%104.82M
0
0
97.03%-27K
Net common stock issuance
----
--0
--0
--0
--0
--0
17.92%105.75M
--0
--0
--0
Proceeds from stock option exercised by employees
----
141.23%275K
--0
--274K
--1K
--0
1,800.00%114K
--0
--0
--0
Net other financing activities
----
----
----
----
----
----
70.30%-1.05M
--0
--0
97.03%-27K
Cash from discontinued financing activities
Financing cash flow
----
-99.74%275K
--0
--274K
103.70%1K
--0
21.65%104.82M
--0
--0
97.03%-27K
Net cash flow
Beginning cash position
-53.82%35.02M
0.93%75.84M
-57.81%32.5M
-55.89%42.33M
-63.39%64.72M
0.93%75.84M
47,456.33%75.14M
-24.38%77.01M
418.47%95.96M
1,332.78%176.78M
Current changes in cash
114.43%1.61M
-5,922.97%-40.82M
315.08%2.53M
48.11%-9.83M
72.30%-22.39M
-110.94%-11.12M
-99.07%701K
95.60%-1.17M
-122.73%-18.95M
-1,409.85%-80.82M
End cash Position
-43.41%36.63M
-53.82%35.02M
-53.82%35.02M
-57.81%32.5M
-55.89%42.33M
-63.39%64.72M
0.93%75.84M
0.93%75.84M
-24.38%77.01M
418.47%95.96M
Free cash flow
40.76%-8.61M
-7.58%-45.65M
-7.34%-11.83M
47.98%-10.18M
-61.54%-9.1M
-134.15%-14.54M
-78.55%-42.44M
-55.64%-11.02M
-404.49%-19.57M
1.50%-5.63M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 40.76%-8.61M-7.58%-45.65M-7.34%-11.83M47.98%-10.18M-61.54%-9.1M-134.15%-14.54M-78.55%-42.44M-55.64%-11.02M-404.49%-19.57M1.50%-5.63M
Net income from continuing operations 41.41%-10.65M-12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M
Other non cash items 0.00%39K4.14%151K0.00%37K0.00%37K8.57%38K8.33%39K4.32%145K2.78%37K5.71%37K2.94%35K
Change In working capital -88.70%301K-0.48%-1.05M-217.23%-4.29M111.67%701K-108.46%-125K1,571.82%2.66M-7.16%-1.05M1,407.86%3.66M-1,123.17%-6.01M7,485.00%1.48M
-Change in prepaid assets 56.77%-297K-36,500.00%-1.83M-108.69%-283K80.85%-825K-108.58%-35K-207.34%-687K99.47%-5K679.36%3.26M-463.27%-4.31M-0.97%408K
-Change in payables and accrued expense -81.21%637K202.43%929K-994.82%-3.97M194.16%1.56M-104.67%-51K533.50%3.39M-855.83%-907K38.75%444K-219.51%-1.66M375.51%1.09M
-Change in other current liabilities 0.00%-39K-11.76%-152K2.63%-37K0.00%-37K-77.27%-39K0.00%-39K6.85%-136K0.00%-38K0.00%-37K38.89%-22K
Cash from discontinued investing activities
Operating cash flow 40.76%-8.61M-7.58%-45.65M-7.34%-11.83M47.98%-10.18M-61.54%-9.1M-134.15%-14.54M-78.55%-42.44M-55.64%-11.02M-404.49%-19.57M1.50%-5.63M
Investing cash flow
Cash flow from continuing investing activities 199.33%10.22M107.39%4.56M45.77%14.36M-87.98%75K82.32%-13.29M13.77%3.41M-590.33%-61.68M150.20%9.85M624K-687.16%-75.16M
Net investment purchase and sale 199.33%10.22M107.39%4.56M45.77%14.36M-87.98%75K82.32%-13.29M13.77%3.41M-590.33%-61.68M150.20%9.85M--624K-687.16%-75.16M
Cash from discontinued investing activities
Investing cash flow 199.33%10.22M107.39%4.56M45.77%14.36M-87.98%75K82.32%-13.29M13.77%3.41M-590.33%-61.68M150.20%9.85M--624K-687.16%-75.16M
Financing cash flow
Cash flow from continuing financing activities -99.74%275K0274K103.70%1K021.65%104.82M0097.03%-27K
Net common stock issuance ------0--0--0--0--017.92%105.75M--0--0--0
Proceeds from stock option exercised by employees ----141.23%275K--0--274K--1K--01,800.00%114K--0--0--0
Net other financing activities ------------------------70.30%-1.05M--0--097.03%-27K
Cash from discontinued financing activities
Financing cash flow -----99.74%275K--0--274K103.70%1K--021.65%104.82M--0--097.03%-27K
Net cash flow
Beginning cash position -53.82%35.02M0.93%75.84M-57.81%32.5M-55.89%42.33M-63.39%64.72M0.93%75.84M47,456.33%75.14M-24.38%77.01M418.47%95.96M1,332.78%176.78M
Current changes in cash 114.43%1.61M-5,922.97%-40.82M315.08%2.53M48.11%-9.83M72.30%-22.39M-110.94%-11.12M-99.07%701K95.60%-1.17M-122.73%-18.95M-1,409.85%-80.82M
End cash Position -43.41%36.63M-53.82%35.02M-53.82%35.02M-57.81%32.5M-55.89%42.33M-63.39%64.72M0.93%75.84M0.93%75.84M-24.38%77.01M418.47%95.96M
Free cash flow 40.76%-8.61M-7.58%-45.65M-7.34%-11.83M47.98%-10.18M-61.54%-9.1M-134.15%-14.54M-78.55%-42.44M-55.64%-11.02M-404.49%-19.57M1.50%-5.63M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More